Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Dec 8;82(1):157–160. doi: 10.1054/bjoc.1999.0893

Expression of cytokeratin 20 in thyroid carcinomas and peripheral blood detected by reverse transcription polymerase chain reaction

T Weber 1, J Lacroix 1, J Weitz 1, K Amnan 2, A Magener 2, T Hölting 3, E Klar 3, C Herfarth 3, M von Knebel Doeberitz 1
PMCID: PMC2363210  PMID: 10638983

Abstract

We investigated a nested reverse transcriptase polymerase chain reaction (RT-PCR) system to detect CK20 mRNA in thyroid carcinomas, benign thyroid diseases and peripheral blood to improve diagnosis of thyroid carcinoma and to detect disseminated tumour cells. Frozen tissue samples of 46 thyroid carcinomas and 30 benign thyroid diseases (14 multinodular goiters, 14 follicular adenomas, two Hashimoto's hyroiditis) were obtained intraoperatively. Preoperative blood samples were drawn from 31 patients with thyroid cancer, nine patients with benign thyroid disorders and 20 healthy volunteers. Nine out of nine medullary, 9/12 follicular, 7/19 papillary and 2/6 anaplastic carcinomas expressed CK20 transcripts. CK20 mRNA was undetectable in 30 tissue sections of benign thyroid diseases. Circulating tumour cells were found in the blood of 3/8 patients with medullary carcinoma, 2/8 patients with follicular carcinoma, 2/11 patients with papillary carcinoma and 1/4 patients with an anaplastic carcinoma. Nine blood samples of patients with benign thyroid diseases and 20 healthy volunteers tested negative. For the first time CK20 mRNA could be detected in tissue sections of thyroid carcinomas and peripheral blood samples of patients with thyroid cancer. It was not detectable in benign thyroid diseases. Our results therefore strongly suggest that CK20 RT-PCR assays may improve the diagnosis of thyroid carcinoma and is able to detect circulating tumour cells in peripheral blood of thyroid carcinoma patients. © 2000 Cancer Research Campaign

Keywords: thyroid carcinoma, cytokeratin 20, circulating tumour cells, polymerase chain reaction

Full Text

The Full Text of this article is available as a PDF (81.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burchill S. A., Bradbury M. F., Pittman K., Southgate J., Smith B., Selby P. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer. 1995 Feb;71(2):278–281. doi: 10.1038/bjc.1995.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Gharib H. Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect. Mayo Clin Proc. 1994 Jan;69(1):44–49. doi: 10.1016/s0025-6196(12)61611-5. [DOI] [PubMed] [Google Scholar]
  3. Ghossein R. A., Rosai J. Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer. 1996 Jul 1;78(1):10–16. doi: 10.1002/(SICI)1097-0142(19960701)78:1<10::AID-CNCR3>3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
  4. Gunn J., McCall J. L., Yun K., Wright P. A. Detection of micrometastases in colorectal cancer patients by K19 and K20 reverse-transcription polymerase chain reaction. Lab Invest. 1996 Oct;75(4):611–616. [PubMed] [Google Scholar]
  5. Johnson P. W., Burchill S. A., Selby P. J. The molecular detection of circulating tumour cells. Br J Cancer. 1995 Aug;72(2):268–276. doi: 10.1038/bjc.1995.324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Klein A., Zemer R., Buchumensky V., Klaper R., Nissenkorn I. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma. Cancer. 1998 Jan 15;82(2):349–354. [PubMed] [Google Scholar]
  7. Moll R., Löwe A., Laufer J., Franke W. W. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol. 1992 Feb;140(2):427–447. [PMC free article] [PubMed] [Google Scholar]
  8. Moll R., Schiller D. L., Franke W. W. Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns. J Cell Biol. 1990 Aug;111(2):567–580. doi: 10.1083/jcb.111.2.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Moll R., Zimbelmann R., Goldschmidt M. D., Keith M., Laufer J., Kasper M., Koch P. J., Franke W. W. The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas. Differentiation. 1993 Jun;53(2):75–93. doi: 10.1111/j.1432-0436.1993.tb00648.x. [DOI] [PubMed] [Google Scholar]
  10. Ringel M. D., Ladenson P. W., Levine M. A. Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood. J Clin Endocrinol Metab. 1998 Dec;83(12):4435–4442. doi: 10.1210/jcem.83.12.5346. [DOI] [PubMed] [Google Scholar]
  11. Roth-Isigkeit A., Brechmann J., Dibbelt L., Sievers H. H., Raasch W., Schmucker P. Persistent endocrine stress response in patients undergoing cardiac surgery. J Endocrinol Invest. 1998 Jan;21(1):12–19. doi: 10.1007/BF03347280. [DOI] [PubMed] [Google Scholar]
  12. Schlumberger M. J. Papillary and follicular thyroid carcinoma. N Engl J Med. 1998 Jan 29;338(5):297–306. doi: 10.1056/NEJM199801293380506. [DOI] [PubMed] [Google Scholar]
  13. Schröder S., Wodzynski A., Padberg B. Zytokeratinexpression benigner und maligner epithelialer Schilddrüsentumoren. Eine immunohistologische Untersuchung an 154 Neoplasien unter Einsatz von 8 verschiedenen monoklonalen Zytokeratinantikörpern. Pathologe. 1996 Nov;17(6):425–432. doi: 10.1007/s002920050181. [DOI] [PubMed] [Google Scholar]
  14. Smanik P. A., Ryu K. Y., Theil K. S., Mazzaferri E. L., Jhiang S. M. Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter. Endocrinology. 1997 Aug;138(8):3555–3558. doi: 10.1210/endo.138.8.5262. [DOI] [PubMed] [Google Scholar]
  15. Soeth E., Vogel I., Röder C., Juhl H., Marxsen J., Krüger U., Henne-Bruns D., Kremer B., Kalthoff H. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res. 1997 Aug 1;57(15):3106–3110. [PubMed] [Google Scholar]
  16. Tallini G., Ghossein R. A., Emanuel J., Gill J., Kinder B., Dimich A. B., Costa J., Robbins R., Burrow G. N., Rosai J. Detection of thyroglobulin, thyroid peroxidase, and RET/PTC1 mRNA transcripts in the peripheral blood of patients with thyroid disease. J Clin Oncol. 1998 Mar;16(3):1158–1166. doi: 10.1200/JCO.1998.16.3.1158. [DOI] [PubMed] [Google Scholar]
  17. Tezelman S., Clark O. H. Current management of thyroid cancer. Adv Surg. 1995;28:191–221. [PubMed] [Google Scholar]
  18. Weitz J., Kienle P., Lacroix J., Willeke F., Benner A., Lehnert T., Herfarth C., von Knebel Doeberitz M. Dissemination of tumor cells in patients undergoing surgery for colorectal cancer. Clin Cancer Res. 1998 Feb;4(2):343–348. [PubMed] [Google Scholar]
  19. Wyld D. K., Selby P., Perren T. J., Jonas S. K., Allen-Mersh T. G., Wheeldon J., Burchill S. A. Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20. Int J Cancer. 1998 Jun 19;79(3):288–293. doi: 10.1002/(sici)1097-0215(19980619)79:3<288::aid-ijc14>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES